题名 | Efficacy and safety of sparsentan versus irbesartan in patients with IgA nephropathy (PROTECT): 2-year results from a randomised, active-controlled, phase 3 trial |
链接 | https://pubmed.ncbi.nlm.nih.gov/37931634/ |
https://pubmed.ncbi.nlm.nih.gov/37931634/
欢迎光临 科研速递论坛 (http://expaper.cn/) | Powered by Discuz! X2.5 |